MedTrace Logo

EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study

NCT00632450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2019-02-05

No results posted yet for this study

Summary

The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant.

Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Johannes Sperzel, MD · Kerckhoff Klinik GmbH

  • Andre d'Avila, MD · Massachusetts General Hospital

  • Imran Niazi, MD · Arrhythmia Center of Southern Wisconsin, Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00632450 on ClinicalTrials.gov